Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.500
-0.090 (-2.51%)
Apr 28, 2026, 4:08 PM HKT
-37.72%
Market Cap 15.81B
Revenue (ttm) 14.90B
Net Income (ttm) 1.79B
Shares Out 4.52B
EPS (ttm) 0.39
PE Ratio 8.86
Forward PE 8.33
Dividend 0.18 (5.02%)
Ex-Dividend Date Jun 2, 2026
Volume 21,648,860
Average Volume 34,934,462
Open 3.590
Previous Close 3.590
Day's Range 3.500 - 3.620
52-Week Range 3.500 - 7.390
Beta 0.41
RSI 30.26
Earnings Date Mar 27, 2026

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ... [Read more]

Sector Healthcare
Founded 1988
Employees 13,307
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1066
Full Company Profile

Financial Performance

In 2025, HKG:1066's revenue was 13.39 billion, an increase of 2.31% compared to the previous year's 13.09 billion. Earnings were 1.61 billion, a decrease of -21.99%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.